Predicting the Effect of Gonadotropin-Releasing Hormone (GnRH) Analogue Treatment on Uterine Leiomyomas Based on MR Imaging
暂无分享,去创建一个
[1] 小口 治. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy : correlation between T2-weighted images and effect of GnRH analogue , 1998 .
[2] Y. Yamashita,et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. , 1993, Radiology.
[3] K. Sugimura,et al. MR Detection of Degenerating Uterine Leiomyomas , 1993, Journal of computer assisted tomography.
[4] H. Minaguchi,et al. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas. , 2010, Asia-Oceania journal of obstetrics and gynaecology.
[5] H. Okamura,et al. Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma. , 1990, Endocrinologia japonica.
[6] P. Googe,et al. Histopathological changes in leiomyomata treated with leuprolide acetate. , 1990, Fertility and sterility.
[7] S. Mccarthy,et al. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging. , 1990, Radiology.
[8] A. Megibow,et al. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. , 1990, AJR. American journal of roentgenology.
[9] E. Zerhouni,et al. A Placebo-Controlled Trial of a Depot Gonadotropin-Releasing Hormone Analogue (Leuprolide) in the Treatment of Uterine Leiomyomata , 1989, Obstetrics and gynecology.
[10] H. Hricak,et al. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. , 1988, American journal of obstetrics and gynecology.
[11] R. Barbieri,et al. A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. , 1988, Fertility and sterility.
[12] H. Judd,et al. Treatment of Endometriosis With a Long‐Acting Gonadotropin‐Releasing Hormone Agonist , 1987, Obstetrics and gynecology.
[13] H. Hricak,et al. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. , 1986, Radiology.
[14] J. Lee,et al. The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens. , 1985, Radiology.
[15] J. Fitzsimmons,et al. MR Imaging of Uterine Leiomyomas and Their Complications , 1985, Journal of computer assisted tomography.
[16] M. Soules,et al. Leiomyomas: steroid receptor content. Variation within normal menstrual cycles. , 1982, American journal of obstetrics and gynecology.
[17] E. Wallach,et al. Uterine leiomyomata: etiology, symptomatology, and management. , 1981, Fertility and sterility.
[18] E. D. Rees,et al. Estradiol and Progesterone Binding in Uterine Leiomyomata and in Normal Uterine Tissues , 1980, Obstetrics and gynecology.